DNA Storage: The Fix Starts With Less DNA, Not More
▼ Summary
– BioCompute addresses the escalating costs of cold data storage by developing a reusable DNA template system instead of synthesizing new strands.
– The company has achieved a write cost of $1 per megabyte and is engineering a full-stack device that integrates enzymatic writing with nanopore reading.
– Founder Anagha Rajesh leverages her background in gene therapy and co-authored textbooks to lead the deep-tech incubation effort from Berkeley.
– The business strategy begins with affordable archival storage but aims to expand into faster data tiers and biomolecular computing.
– By reusing DNA templates, BioCompute targets a long-term goal of reducing storage costs to $1 per terabyte while utilizing biology as an information medium.
The global explosion of digital information has created a storage crisis that traditional hardware cannot solve affordably. We generate more data annually than we can practically retain, yet most of this content is “cold,” meaning it is rarely accessed but never deleted. Consequently, it sits on degrading tapes and disks that require constant power, maintenance, and periodic replacement. These costs compound relentlessly, creating an unsustainable financial burden for organizations worldwide.
While DNA storage offers a tantalizing solution due to its extreme density and longevity, the industry has historically focused on the wrong metric: the cost of manufacturing new DNA strands. BioCompute, a Berkeley-incubated deep-tech company, argues that this approach is fundamentally flawed. Instead of consuming material, their strategy revolves around reusing DNA templates. By marking existing strands rather than synthesizing new ones, BioCompute shifts the paradigm from consumption to reuse, a distinction that defines their entire operational model.
This theoretical shift is backed by rapid empirical progress. BioCompute has demonstrated a writing cost of just $1 per megabyte, significantly undercutting traditional synthesis methods. However, their true innovation lies in building a full-stack data storage device. Typically, writing and reading DNA are treated as disjointed tasks handled by separate tools. BioCompute engineers these processes as an integrated system, pairing an enzymatic write process with a licensed nanopore read technology they are actively tuning. This synergy allows them to aim for a target of $1 per terabyte, driving down costs by ensuring the write and read mechanisms are optimized for each other.
The leadership behind this venture combines academic rigor with practical ambition. Founder Anagha Rajesh left a PhD in gene therapy at Oxford to establish the company. She co-authored what is considered the first textbook on DNA data storage and regularly writes about data infrastructure and deep tech. Her incoming cofounder unifies signal acquisition and molecular biology, two disciplines essential for clean writing and reliable reading of genetic data.
Rajesh views cold storage merely as the entry point. The underlying principle,that information can be encoded into molecules and retrieved later,suggests applications far beyond archival purposes. The company’s long-term vision ascends the latency ladder, moving from slow archives toward faster data tiers. Ultimately, BioCompute aims to transition from simply storing data in biology to using biomolecules for active computing. As Rajesh states, “storage is only the beachhead market.” The goal is to leverage biology not just as a medium for keeping data safe, but as a functional layer for processing information itself.
(Source: The Next Web)
